Vivek Ramaswamy is a New York Times best-selling author and a successful entrepreneur who has founded multiple successful enterprises. A first-generation American, he is the founder and executive chairman of Roivant Sciences, a new type of biopharmaceutical company focused on the application of technology to drug development. He founded Roivant in 2014 and led the largest biotech IPOs of 2015 and 2016, eventually culminating in successful clinical trials in multiple disease areas that led to FDA-approved products.
Ramaswamy was born and raised in southwest Ohio. He graduated summa cum laude in Biology from Harvard in 2007 and began his career as a successful biotech investor at a prominent hedge fund. He continued to work as an investor while earning his law degree at Yale. Ramaswamy was featured on the cover of Forbes magazine in 2015 for his work in drug development. In 2020, he emerged as a prominent commentator on stakeholder capitalism, free speech, and woke culture.
He has authored numerous articles and op-eds, which have appeared in the Wall Street Journal, the New York Times, National Review, Newsweek, and Harvard Business Review. Ramaswamy serves on the board of directors of the Philanthropy Roundtable, the Foundation for Research on Equal Opportunity, and St. Xavier High School.